Bicycle Therapeutics plc (BCYC) Tops Q2 EPS by 36c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q2 EPS of ($0.77), $0.36 better than the analyst estimate of ($1.13). Revenue for the quarter came in at $9.36 million versus the consensus estimate of $6.13 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• Is the global equity rally broadening? UBS weighs in
• OBOOK Holdings posts $18.8M net loss as OwlPay Harbor volume rises